1. Home
  2. MLAB vs NMAI Comparison

MLAB vs NMAI Comparison

Compare MLAB & NMAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mesa Laboratories Inc.

MLAB

Mesa Laboratories Inc.

HOLD

Current Price

$93.08

Market Cap

489.8M

Sector

Industrials

ML Signal

HOLD

Logo Nuveen Multi-Asset Income Fund of Beneficial Interest

NMAI

Nuveen Multi-Asset Income Fund of Beneficial Interest

HOLD

Current Price

$13.61

Market Cap

440.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLAB
NMAI
Founded
1982
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Investment Managers
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
489.8M
440.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MLAB
NMAI
Price
$93.08
$13.61
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$94.00
N/A
AVG Volume (30 Days)
94.2K
74.8K
Earning Date
02-03-2026
01-01-0001
Dividend Yield
0.70%
13.14%
EPS Growth
N/A
N/A
EPS
0.68
0.64
Revenue
$247,541,000.00
N/A
Revenue This Year
$4.96
N/A
Revenue Next Year
$4.85
N/A
P/E Ratio
$134.88
$19.03
Revenue Growth
4.12
N/A
52 Week Low
$55.45
$10.60
52 Week High
$155.12
$12.55

Technical Indicators

Market Signals
Indicator
MLAB
NMAI
Relative Strength Index (RSI) 65.05 56.31
Support Level $77.48 $13.37
Resistance Level $98.14 $13.62
Average True Range (ATR) 3.89 0.12
MACD 0.84 0.00
Stochastic Oscillator 68.60 71.43

Price Performance

Historical Comparison
MLAB
NMAI

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

About NMAI Nuveen Multi-Asset Income Fund of Beneficial Interest

Nuveen Multi-Asset Income Fund is a closed-end management investment company. The Fund dynamically invests in a portfolio of equity and debt securities of issuers located around the world. This dynamic investment uses a risk-based framework in which any amount can be allocated to an asset-class at any time. The Fund may invest in equity and debt securities of any type without limit.

Share on Social Networks: